Yu J Cao

8PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsReaction engineering (excl. nuclear reactions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2026
Targeting TMED4 enhances CD8+ T cell function and CAR T cell efficacy in solid tumors through the IRE1α-autophagy axis.

|Jan 19, 2026
Unique loop-structured CD19/CD22 bispecific CAR-T-cell therapy for patients with relapsed/refractory diffuse large B-cell lymphoma: an observational study.

Shuhong Li, Liqiong Liu, Zelin Liu

|Jun 27, 2025
BAFF-based trifunctional T-cell engagers trigger robust tumor immunity against B-cell malignancies.

Shuhong Li, Licai Shi, Qiaoru Guo

|Nov 11, 2024
Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies.

Shuhong Li, Licai Shi, Lijun Zhao

|Oct 17, 2023
Applications of genetic code expansion technology in eukaryotes.

Qiao-Ru Guo, Yu J Cao

|Aug 18, 2022
A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL.

Lijun Zhao, Shuhong Li, Xiaoyi Wei

Pageof 2

Frequent Collaborators

1 joint publications

Hwayoung Yun

1 joint publications

Feng Wang

1 joint publications

Huizi Wang

1 joint publications

Licai Shi